Robotic Minimally Invasive Ventral Hernia Repair With DEXTER
Launched by DISTALMOTION SA · Jul 8, 2025
Trial Information
Current as of November 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new robotic system called Dexter to help with ventral hernia repair, which is a type of surgery to fix a bulge or weakness in the abdominal wall. The goal is to see if using this robot during surgery is safe and works well for patients having this procedure, especially for hernias located around the middle of the belly that are 8 centimeters or smaller.
Adults over 18 who need surgery for a primary or incisional ventral hernia in specific areas of the abdomen may be eligible to join, as long as they don’t have other health issues like infections, ongoing blood-thinning treatments, or previous major abdominal surgeries. Participants will have the robotic-assisted surgery and then follow-up visits for about 30 days to check on their recovery. This study is currently looking for volunteers and aims to help improve hernia repair by using advanced robotic technology that could make the surgery less invasive and potentially safer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged \> 18 years
- • Planned to undergo incisional and primary midline ventral (M2-M4; epigastric, umbilical and infraumbilical) hernia repair smaller and equal to 8cm
- • Patient agrees to perform the 30-day follow-up assessment, as per standard of care
- Exclusion Criteria:
- • Any planned concomitant procedures
- • Active anticoagulant treatment
- • Recurring hernia with mesh during primary hernia repair
- • Need for transversal abdominal release
- • Patients under corticosteroids or other immunosuppressive treatment
- • Loss of domain type of hernia
- • Previous incision extending from xiphoid process to pubic bone (= Median laparotomy M1 to M5)
- • M2 hernia extending to M1 and/or M4 hernia extending to M5
- • Ongoing intra-abdominal infection or septic state
- • Abdominal fistulae
- • History of major\* abdominal or pelvic surgery
About Distalmotion Sa
Distalmotion SA is an innovative medical technology company dedicated to advancing surgical robotics and enhancing minimally invasive procedures. Based in Switzerland, the company leverages cutting-edge technology to develop intuitive robotic systems that improve surgical precision, reduce recovery times, and optimize patient outcomes. With a commitment to clinical excellence and collaboration, Distalmotion SA focuses on addressing the evolving needs of healthcare professionals and patients through rigorous research and development, ensuring that their solutions are both effective and accessible in the rapidly changing landscape of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winterthur, Switzerland
Spittal An Der Drau, Austria
Saintes, France
München, Germany
Zürich, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported